Histopathology services to support 5 efficacy studies starting with prepared slides. Options for additional studies starting with prepared slides as well as studies starting with fixed tissues.
Active Purchase Order Awarded Last action
- Contract number
- 75N93024P01204
- Awardee
-
Experimental Pathology Laboratories, Inc. UEI E4S8XBDQ4AN1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $217,776
Award facts
- Opportunity
-
- Histopathology Services to Support On-going Small Animal Product Efficacy Studies for Viruses with Pandemic Potential Pre-Solicitation · RFQNIAID242226993 · Posted Aug 9, 2024
- Contract value 27% obligated
-
- $217,776.00 Current, with exercised options
- $803,683.20 Potential, with all options
- Completion date 69% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541940 Veterinary Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $129,912 | |
| Original award | $87,864 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order valued at $803,683.20 to Experimental Pathology Laboratories, Inc. (EPL), a Sterling, Virginia-based contract research organization specializing in toxicology and pathology services. This unrestricted procurement, awarded on September 25, 2024, with completion targeted for September 24, 2027, provides histopathology services to support small animal product efficacy studies focused on viruses with pandemic potential. The contract encompasses a base period of five efficacy studies utilizing prepared slides and five studies utilizing fixed tissues, with options for additional studies in both categories.
Under this contract, EPL will deliver comprehensive histopathology services including tissue evaluation and interpretation, representative image capture, and audited pathology reports prepared by board-certified veterinary pathologists and experienced histopathology technicians. The work scope includes slide preparation from fixed rodent tissues and analysis of up to 60 animals per study with multiple tissue samples targeting lung, liver, spleen, and brain tissues. As a long-established federal contractor registered with the System for Award Management since 2002, EPL brings significant experience supporting NIAID and other federal agencies in complex scientific research involving histological examination and pathology reporting. No set-aside designation applies to this award.
Quick answers
Who was awarded contract 75N93024P01204?
75N93024P01204 was awarded to Experimental Pathology Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 25, 2024.
How much is contract 75N93024P01204 worth?
The government has obligated $217,776 on 75N93024P01204. Its potential value, with all options, is $803,683.
Was contract 75N93024P01204 competed?
The extent of competition for 75N93024P01204 was competed under sap. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award